We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$41B
AUM Growth
+$146M
(+0.36%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-3.25%
Top 10 Holdings %
Top 10 Hldgs %
14.19%
Holding
825
New
119
Increased
275
Reduced
226
Closed
119
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$226M |
| 2 |
AGN
Allergan plc
AGN
|
+$166M |
| 3 |
NRF
NorthStar Realty Finance Corp.
NRF
|
+$152M |
| 4 |
Procter & Gamble
PG
|
+$150M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$382M |
| 2 |
AGN
Allergan Inc
AGN
|
+$274M |
| 3 |
CF Industries
CF
|
+$189M |
| 4 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$164M |
| 5 |
ROC
ROCKWOOD HLDGS INC
ROC
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.99% |
| 2 | Technology | 12.21% |
| 3 | Financials | 11% |
| 4 | Industrials | 9.97% |
| 5 | Consumer Discretionary | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Lockheed Martin
LMT
$132B
| $143M | 0.35% |
704,222
+320,088
| +83% | +$63.2M |
|
77
Conagra Brands
CAG
$7.19B
| $141M | 0.34% |
4,959,126
+1,721,900
| +53% | +$47.5M |
|
|
FDO
78
DELISTED
FAMILY DOLLAR STORES
FDO
| $140M | 0.34% |
1,771,844
+1,400,344
| +377% | +$109M |
|
79
Boeing
BA
$175B
| $140M | 0.34% |
935,466
-329,843
| -26% | -$48M |
|
|
MON
80
DELISTED
Monsanto Co
MON
| $140M | 0.34% |
1,245,038
-175,000
| -12% | -$20.8M |
|
|
DTV
81
DELISTED
DIRECTV COM STK (DE)
DTV
| $137M | 0.33% |
1,614,600
+199,900
| +14% | +$17.3M |
|
82
Zurn Elkay Water Solutions
ZWS
$8.31B
| $136M | 0.33% |
10,616,913
-635,844
| -6% | -$8.14M |
|
|
SIAL
83
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $136M | 0.33% |
980,479
+131,501
| +15% | +$18.1M |
|
|
PCYC
84
DELISTED
PHARMACYCLICS INC
PCYC
| $135M | 0.33% |
+528,632
| New | +$102M |
|
85
AbbVie
ABBV
$455B
| $135M | 0.33% |
2,310,875
-42,000
| -2% | -$2.54M |
|
86
Edison International
EIX
$30.3B
| $133M | 0.32% |
2,122,700
-850,000
| -29% | -$55.4M |
|
87
J.M. Smucker
SJM
$13.1B
| $129M | 0.31% |
1,114,154
-145,956
| -12% | -$16M |
|
88
Mastercard
MA
$510B
| $128M | 0.31% |
1,483,210
+91,000
| +7% | +$7.89M |
|
89
Eli Lilly
LLY
$1.03T
| $126M | 0.31% |
1,741,200
+104,000
| +6% | +$7.4M |
|
90
General Dynamics
GD
$103B
| $126M | 0.31% |
929,016
+309,550
| +50% | +$42.5M |
|
91
Boston Scientific
BSX
$68.4B
| $124M | 0.3% |
7,010,112
-1,450,000
| -17% | -$22.9M |
|
92
Amgen
AMGN
$209B
| $120M | 0.29% |
747,959
+163,338
| +28% | +$25.7M |
|
93
Thermo Fisher Scientific
TMO
$214B
| $120M | 0.29% |
889,929
+385,265
| +76% | +$49.7M |
|
94
Goldman Sachs
GS
$302B
| $118M | 0.29% |
627,200
+182,000
| +41% | +$33.9M |
|
95
Snap-on
SNA
$21.2B
| $118M | 0.29% |
801,338
-522,612
| -39% | -$73.5M |
|
96
Magna International
MGA
$19B
| $115M | 0.28% |
2,155,022
+700,000
| +48% | +$36M |
|
97
Kinder Morgan
KMI
$70.5B
| $113M | 0.28% |
2,697,679
+1,354,232
| +101% | +$56.1M |
|
98
Constellium
CSTM
$3.87B
| $113M | 0.28% |
5,552,183
+397,601
| +8% | +$7.46M |
|
99
McKesson
MCK
$101B
| $112M | 0.27% |
496,208
+36,000
| +8% | +$7.98M |
|
100
Coca-Cola Europacific Partners
CCEP
$49.3B
| $111M | 0.27% |
2,515,404
-1,020,000
| -29% | -$44.5M |
|
Similar funds
Adage Capital Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Adage Capital Partners held 825 positions worth $41B, up 0.36% from $40.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Adage Capital Partners withdrew a net $1.33B in Q1 2015, closing 119 positions and reducing 226 holdings. Its most notable exit was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $382M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
Against the trend, Adage Capital Partners opened a new position in Medtronic worth $232M.
- Adage Capital Partners's largest Q1 2015 buy was Medtronic: 2,976,347 shares worth $232M.
- Adage Capital Partners added most to Allergan plc in Q1 2015, an estimated $166M increase.
- Adage Capital Partners's biggest Q1 2015 reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, cutting an estimated $164M.
- Adage Capital Partners fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $382M.
- Adage Capital Partners's ten largest holdings make up 14% of its $41B portfolio in Q1 2015.
- Adage Capital Partners opened 119 new positions and closed 119 in Q1 2015.
- Adage Capital Partners's portfolio value rose 0.36% quarter-over-quarter to $41B.
Based on Adage Capital Partners's 13F filing for Q1 2015, filed 15 May 2015.